The offer is conditional upon SCA achieving an ownership share in Vinda in excess of 50%.
Vinda is the third largest tissue company in China, (after APP and Hengan) which represents the world’s second largest tissue market.
SCA became a part owner in Vinda in 2007 and currently has a 21,7% holding in the company with two representatives on its Board of Directors. The offer will be Hong Kong Dollar, 11 HKD, per share, and corresponds to a market capitalization of approximately SEK 9,4 bn for all shares in Vinda.